… and clinical features of covid-19, the … of patients with covid-19 pneumonia. The review
is aimed at clinicians and intensivists caring for patients with severe covid-19 pneumonia as …

… In this phase 3 trial, we randomly assigned patients who were hospitalized with severe
Covid-19 pneumonia in a 2:1 ratio receive a single intravenous infusion of tocilizumab (at a dose …

… data on mortality predictors in severe COVID-19 pneumonia patients admitted to ICU in the
… in patients with severe COVID-19 pneumonia admitted to a tertiary care COVID-19 hospital …

… patients with severe COVID-19 infection [5]. The rationale for prolonged, low-dose corticosteroid
treatment in severe COVID-19 … hypoxemic patients with severe SARS-CoV-2 pneumonia …

… associated with severe/critical COVID-19 pneumonia by comparing severe/critical patients
with ordinary patients. In this study, we found that the severe/critical patients were older and …

… Coronavirus disease 2019 (COVID-19) pneumonia is an evolving disease. We will focus on
… the coexistence, in a significant fraction of patients, of severe hypoxaemia, near-normal lung …

… benefit than remdesivir alone in patients with severe COVID-19 pneumonia. … patients
hospitalized with severe COVID-19 pneumonia requiring > 6 L/min supplemental oxygen. Patients …

… A total of 46 hospitalized patients with severe COVID-19 pneumonia were diagnosed
and included in this study, the age, sex, comorbidities, clinical and laboratory parameters on …

… We recommend that patients cared for in ICU or those with severe COVID-19 pneumonia
(box 2) should undergo an early follow-up assessment at 4–6 weeks after discharge. …

… of the COVID-19 pneumonia patients evaluated after contrast administration had acute PE on
… patients with COVID-19 pneumonia, particularly in those with marked elevation of D-dimer. …